Premium
Neuropathologic differences by race from the National Alzheimer's Coordinating Center
Author(s) -
GraffRadford Neill R.,
Besser Lilah M.,
Crook Julia E.,
Kukull Walter A.,
Dickson Dennis W.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.03.004
Subject(s) - neuropathology , apolipoprotein e , dementia , frontotemporal lobar degeneration , disease , medicine , demographics , lewy body , alzheimer's disease , psychology , gerontology , pathology , frontotemporal dementia , demography , sociology
Compared to Caucasians, African Americans (AAs) have higher dementia prevalence, different genetic markers, and higher vascular risk factors. However, pathologic underpinnings are unknown. Methods We used neuropathologic and clinical data on 110 AA and 2500 Caucasians who were demented before death. The groups were compared regarding demographics, cognition, apolipoprotein E ( APOE ) genotype, comorbidities, and clinical and neuropathologic characteristics. Results AA and Caucasians differed in their demographics, cognition at the last visit before death, APOE genotype, presence of hypertension, primary clinical diagnoses, and AD, cerebrovascular disease (CVD), and other neuropathologies such as Lewy body disease (LBD). Discussion AD, LBD, and CVD pathology were more common and TDP and frontotemporal lobar degeneration–tau less common in AA than in Caucasians. APOE accounted for most of the AD neuropathologic differences. If replicated, the observed differences in underlying neuropathology by race will be important for public health policy and recruitment for and interpreting of clinical trials.